Humacyte, Inc. (HUMA) Tops Q4 EPS by 9c

Humacyte, Inc. (NASDAQ: HUMA) reported Q4 EPS of ($0.16), $0.09 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• NPR retracts story about Justice Alito retiring from Supreme Court
• Anthropic: Claude Science, an AI workbench for scientists, is now available
• BMW slashes profit margin forecast to 1-3%; JPMorgan calls cut "radical" as stock hits six-year low